96 results
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
Initiation of ART in HIV ... patients with Opportunistic ... of starting OI treatment ... Therapy #HAART #HIV ... #Opportunistic
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Women with in HIV-AIDS ... known to have HIV ... diagnosed with HIV ... IDSA #Prevention #Treatment ... #management #opportunistic
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
CNS Infection in HIV ... CNS Opportunistic ... • CNS opportunistic ... Antimicrobial treatment ... InfectiousDiseases #Neurology
Acute Retroviral Syndrome
Acute Retroviral Syndrome is the symptomatic presentation of acute human immunodeficiency virus infection

 •
symptoms • >50,000 HIV ... Presentations: • Opportunistic ... in which case opportunistic ... -1 and HIV-2 • ... antibody test) Treatment
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
of HIV/AIDS patients ... previously diagnosed opportunistic ... • 10-20% of HIV-infected ... a decrease in HIV ... of preexisting opportunistic
Nuchal Rigidity in Infantile Bacterial Meningitis

Flexion of the neck revealed nuchal rigidity. The patient was unable
unable to lower his ... chin to his anterior ... bed as he lifted his ... PhysicalExam #Clinical #Video ... Peds #Pediatrics #neurology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Leishmaniasis in HIV-AIDS ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Infections in HIV-AIDS ... PO (or 400 mg IV ... PO (or 400 mg IV ... IDSA #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Infections in HIV-AIDS ... to 5 mg/kg/day IV ... IDSA #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... for effective treatment ... 400 mg) PO or IV ... IDSA #Prevention #Treatment ... #management #opportunistic